The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study
Open accessAbstract
Aims/hypothesis We determined the effects of 6 years of lifestyle intervention in persons with impaired glucose tolerance (IGT) on the development of retinopathy, nephropathy and neuropathy over a 20 year period.Methods In 1986, 577 adults with IGT from 33 clinics in Da Qing, China were randomly assigned by clinic to a control group or one of three lifestyle intervention groups (diet, exercise, and diet plus exercise). Active intervention was carried out from 1986 to 1992. In 2006 we conducted a 20 year follow-up study of the original participants to compare the incidence of microvascular complications in the combined intervention group vs the control group.Results Follow-up information was obtained on 542 (94%) of the 577 original participants. The cumulative incidence of severe retinopathy was 9.2% in the combined intervention group and 16.2% in the control group (p = 0.03, log-rank test). After adjusting for clinic and age, the incidence of severe retinopathy was 47% lower in the intervention group than the control group (hazard rate ratio 0.53, 95% CI 0.29-0.99, p = 0.048). No significant differences were found in the incidence of severe nephropathy (hazard rate ratio 1.05, 95% CI 0.16-7.05, intervention vs control, p = 0.96) or in the prevalence of neuropathy (8.6% vs 9.1%, p = 0.89) among the 20 year survivors.Conclusions/interpretation Lifestyle intervention for 6 years in IGT was associated with a 47% reduction in the incidence of severe, vision-threatening retinopathy over a 20 year interval, primarily due to the reduced incidence of diabetes in the intervention group. However, similar benefits were not seen for nephropathy or neuropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“while the rates of other microvascular complications, such as nephropathy and neuropathy, were similar as in controls.119”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [119]
In the citing paper
“In the 20-year follow-up of the DaQing Diabetes Prevention Study, for example, those receiving a lifestyle intervention had a 43% reduced risk of diabetes, translating to a mean 3.6 year delay in the development of diabetes.119”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [119]
In the citing paper
“In the 20-year follow-up of the DaQing Study, the lifestyle intervention was also associated with an almost 50% reduction in the relative risk of incident severe retinopathy”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [119]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“Several studies have shown that lifestyle or pharmacological interventions can reduce diabetes incidence in people with impaired glucose tolerance (IGT) [1–7].”
BackgroundPan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320
Self-citationDiabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
* (1991) · Ophthalmology · doi:10.1016/s0161-6420(13)38012-9 · Cited by 2,086
The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Klein, R. (1984) · Archives of Ophthalmology · doi:10.1001/archopht.1984.01040030398010 · Cited by 1,909
Ramachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A. D., Vijay, V., & Indian Diabetes Prevention Programme (IDPP) (2006) · Diabetologia · doi:10.1007/s00125-005-0097-z · Cited by 1,881
Li, G., Zhang, P., Wang, J., Gregg, E. W., Yang, W., Gong, Q., Li, H., Li, H., Jiang, Y., An, Y., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60766-7 · Cited by 1,600
Self-citationThe Wisconsin Epidemiologic Study of Diabetic Retinopathy
Klein, R. (1984) · Archives of Ophthalmology · doi:10.1001/archopht.1984.01040030405011 · Cited by 1,482
Research works printed but not linked: 1
- Anonymous (1985) Diabetes mellitus Report of a WHO Study Group. World Health Organ Tech Rep Ser 727:1–113
Cited by
Sorted by citations
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
Prediabetes: a high-risk state for diabetes development
Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60283-9 · Cited by 2,958
Authors Task Force Members, Rydén, L., Grant, P. J., Anker, S. D., Berne, C., Cosentino, F., Danchin, N., Deaton, C., Escaned, J., Hammes, H., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,994
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62154-6 · Cited by 1,743
Differentiation of diabetes by pathophysiology, natural history, and prognosis
Skyler, J. S., Bakris, G. L., Bonifacio, E., Darsow, T., Eckel, R. H., Groop, L., Groop, P.-H., Handelsman, Y., Insel, R. A., Mathieu, C., et al. (2017) · Diabetes · doi:10.2337/db16-0806 · Cited by 823
Li, G., Zhang, P., Wang, J., An, Y., Gong, Q., Gregg, E. W., Yang, W., Zhang, B., Shuai, Y., Hong, J., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70057-9 · Cited by 684
Self-citationGong, Q., Zhang, P., Wang, J., Ma, J., An, Y., Chen, Y., Zhang, B., Feng, X., Li, H., Chen, X., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30093-2 · Cited by 615
Self-citationRydén, L., Grant, P. J., Anker, S. D., Berne, C., Cosentino, F., Danchin, N., Deaton, C., Escaned, J., Hammes, H., Huikuri, H., et al. (2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.10.013 · Cited by 609
Prediabetes diagnosis and treatment: A review
Bansal, N. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i2.296 · Cited by 579
Schellenberg, E. S., Dryden, D. M., Vandermeer, B., Ha, C., & Korownyk, C. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-8-201310150-00007 · Cited by 520
Diagnosis and Management of Prediabetes: A Review
Echouffo-Tcheugui, J. B., Perreault, L., Ji, L., & Dagogo-Jack, S. (2023) · JAMA · doi:10.1001/jama.2023.4063 · Cited by 473
Prevention of Type 2 Diabetes by Lifestyle Changes: A Systematic Review and Meta-Analysis
Uusitupa, M. I. J., Khan, T. A., Viguiliouk, E., Kahleová, H., Rivellese, A. A., Hermansen, K., Pfeiffer, A. F. H., Thanopoulou, A. C., Salas‐Salvadó, J., Schwab, U., et al. (2019) · Nutrients · doi:10.3390/nu11112611 · Cited by 531
Prediabetes and what it means: the epidemiological evidence
Echouffo-Tcheugui, J. B., & Selvin, E. (2021) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-090419-102644 · Cited by 406
Balk, E. M., Earley, A., Raman, G., Avendano, E. A., Pittas, A. G., & Remington, P. L. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0452 · Cited by 371
Hemmingsen, B., Gimenez-Perez, G., Mauricio, D., Roqué i Figuls, M., Metzendorf, M.-I., & Richter, B. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003054.pub4 · Cited by 316
The importance of weight management in type 2 diabetes mellitus
Wilding, J. P. H. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12384 · Cited by 314
Preventing Type 2 Diabetes in Communities Across the U.S.
Albright, A. L., & Gregg, E. W. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2012.12.009 · Cited by 315
Self-citationNielsen, K. K., Kapur, A., Damm, P., de Courten, M., & Bygbjerg, I. C. (2014) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-14-41 · Cited by 284
Prediabetes and Lifestyle Modification: Time to Prevent a Preventable Disease
Tuso, P. (2014) · The Permanente Journal · doi:10.7812/tpp/14-002 · Cited by 252
Biomarkers in diabetes: hemoglobin A1c, vascular and tissue markers
Lyons, T. J., & Basu, A. (2012) · Translational research · doi:10.1016/j.trsl.2012.01.009 · Cited by 260
pre-diabetes Task Force on diabetes (2014) · Diabetes and Vascular Disease Research · doi:10.1177/1479164114525548 · Cited by 239
Emerging Biomarkers, Tools, and Treatments for Diabetic Polyneuropathy
Bönhof, G. J., Herder, C., Strom, A., Παπάνας, Ν., Roden, M., & Ziegler, D. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00107 · Cited by 231
Novel biomarkers for prediabetes, diabetes, and associated complications
Dorcely, B., Katz, K., Jagannathan, R., Chiang, S. S., Oluwadare, B., Goldberg, I. J., & Bergman, M. (2017) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s100074 · Cited by 236
The epidemic of pre-diabetes: the medicine and the politics
Yudkin, J. S., & Montori, V. M. (2014) · BMJ · doi:10.1136/bmj.g4485 · Cited by 218
Neuropathy in prediabetes: does the clock start ticking early?
Παπάνας, Ν., Vinik, A. I., & Ziegler, D. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.113 · Cited by 218
Effects of lifestyle changes on adults with prediabetes: A systematic review and meta-analysis
Glechner, A., Keuchel, L., Affengruber, L., Titscher, V., Sommer, I., Matyas, N., Wagner, G., Kien, C., Klerings, I., & Gartlehner, G. (2018) · Primary care diabetes · doi:10.1016/j.pcd.2018.07.003 · Cited by 226
Geng, T., Zhu, K., Lu, Q., Wan, Z., Chen, X., Liu, L., Pan, A., & Liu, G. (2023) · PLOS Medicine · doi:10.1371/journal.pmed.1004135 · Cited by 205
3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D. M., et al. (2022) · Diabetes Care · doi:10.2337/dc23-s003 · Cited by 220
3. Prevention or Delay of Type 2 Diabetes:Standards of Medical Care in Diabetes—2021
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc21-s003 · Cited by 217
Sievenpiper, J. L., Chan, C. B., Dworatzek, P. D., Freeze, C., & Williams, S. L. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.009 · Cited by 200
Knowler (2011) · doi:10.1001/archinternmed.2011.367 · Cited by 194
Gruss, S. M., Nhim, K., Gregg, E., Bell, M., Luman, E., & Albright, A. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1200-z · Cited by 179
Self-citationYamagata, K., Hoshino, J., Sugiyama, H., Hanafusa, N., Shibagaki, Y., Komatsu, Y., Konta, T., Fujii, N., Kanda, E., Sofue, T., et al. (2019) · Renal Replacement Therapy · doi:10.1186/s41100-019-0209-8 · Cited by 173
American Diabetes Association Professional Practice Committee (2021) · Diabetes Care · doi:10.2337/dc22-s003 · Cited by 167
Dworatzek, P. D. N., Arcudi, K., Gougeon, R., Husein, N., Sievenpiper, J. L., & Williams, S. L. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.019 · Cited by 157
Azmi, S., Ferdousi, M., Petropoulos, I. N., Ponirakis, G., Alam, U., Fadavi, H., Asghar, O., Marshall, A., Atkinson, A. J., Jones, W., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2733 · Cited by 148
Gillett, M., Royle, P., Snaith, A., Scotland, G., Poobalan, A. S., Imamura, M., Black, C., Boroujerdi, M. A., Jick, S. S., Wyness, L., et al. (2012) · Health Technology Assessment · doi:10.3310/hta16330 · Cited by 150
Management of NCD in Low- and Middle-Income Countries
Checkley, W., Ghannem, H., Irazola, V. E., Kimaiyo, S. N., Levitt, N. S., Miranda, J. J., Niessen, L. W., Prabhakaran, D., Rabadan‐Diehl, C., Ramírez‐Zea, M., et al. (2014) · Global Heart · doi:10.1016/j.gheart.2014.11.003 · Cited by 151
Cefalu, W. T., Buse, J. B., Tuomilehto, J. O., Fleming, G. A., Ferrannini, E., Gerstein, H. C., Bennett, P. H., Ramachandran, A., Raz, I., Rosenstock, J., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0873 · Cited by 148
Self-citationLong-Term Weight Loss Strategies for Obesity
Kheniser, K., Saxon, D. R., & Kashyap, S. R. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab091 · Cited by 139
Tsao, H.-Y., Chan, P.-Y. S., & Su, E. C. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2277-0 · Cited by 136
Carlsson, L. M. S., Sjöholm, K., Karlsson, C., Jacobson, P., Andersson‐Assarsson, J. C., Svensson, P., Larsson, I., Hjorth, S., Neovius, M., Taube, M., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30061-x · Cited by 132
Dunkler, D., Kohl, M., Heinze, G., Teo, K. K., Rosengren, A., Pogue, J., Gao, P., Gerstein, H. C., Yusuf, S., Oberbauer, R. W., et al. (2014) · Kidney International · doi:10.1038/ki.2014.370 · Cited by 125
Clinical Manifestation and Natural History of Diabetic Nephropathy
Ritz, E., Zeng, X., & Rychlík, I. (2011) · Contributions to nephrology · doi:10.1159/000324939 · Cited by 115
We Can Change the Natural History of Type 2 Diabetes
Phillips, L. S., Ratner, R. E., Buse, J. B., & Kahn, S. E. (2014) · Diabetes Care · doi:10.2337/dc14-0817 · Cited by 109
An, Y., Zhang, P., Wang, J., Gong, Q., Gregg, E. W., Yang, W., Li, H., Zhang, B., Shuai, Y., Chen, Y., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2498 · Cited by 99
Self-citationDiabetes in the Western Pacific Region—Past, Present and Future
Chan, J. C. N., Cho, N. H., Tajima, N., & Shaw, J. E. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.012 · Cited by 99
Alouki, K., Delisle, H. F., Bermúdez‐Tamayo, C., & Johri, M. (2016) · Journal of Diabetes Research · doi:10.1155/2016/2159890 · Cited by 94
Periodontitis as a possible early sign of diabetes mellitus
Teeuw, W. J., Kosho, M. X. F., Poland, D. C. W., Gerdes, V. E. A., & Loos, B. G. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000326 · Cited by 96
Does diabetes prevention translate into reduced long-term vascular complications of diabetes?
and the DPP Research Group, Nathan, D. M., Bennett, P. H., Crandall, J. P., Edelstein, S. L., Goldberg, R. B., Kahn, S. E., Knowler, W. C., Mather, K. J., Mudaliar, S., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-4928-8 · Cited by 91
Self-citationMedical Care and Payment for Diabetes in China: Enormous Threat and Great Opportunity
Yang, W., Zhao, W., Xiao, J., Li, R., Zhang, P., Kissimova‐Skarbek, K., Schneider, E., Jia, W., Ji, L., Guo, X., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039513 · Cited by 93
Self-citationEdwards, C., & Cusi, K. J. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.06.007 · Cited by 94
Liu, G., Li, Y., Pan, A., Hu, Y., Chen, S., Qian, F., Rimm, E. B., Manson, J. E., Stampfer, M. J., Giatsidis, G., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.52239 · Cited by 94
Self-citationScreening for Type 2 Diabetes and Dysglycemia
Echouffo-Tcheugui, J. B., Ali, M. K., Griffin, S. J., & Narayan, K. M. V. (2011) · Epidemiologic Reviews · doi:10.1093/epirev/mxq020 · Cited by 87
Andersson-Hall, U. K., Gustavsson, C., Pedersen, A., Malmodin, D., Joelsson, L., & Holmäng, A. B. (2018) · Journal of Diabetes Research · doi:10.1155/2018/4207067 · Cited by 77
Moon, J. S., Kang, S., Choi, J. H., Lee, K. A., Moon, J. H., Chon, S., Kim, D. J., Kim, H. J., Seo, J. A., Kim, M. K., et al. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0249 · Cited by 81
Dental findings and identification of undiagnosed hyperglycemia
Lalla, E., Cheng, B., Kunzel, C., Burkett, S., & Lamster, I. B. (2013) · Journal of Dental Research · doi:10.1177/0022034513502791 · Cited by 73
The emerging role of dyslipidemia in diabetic microvascular complications
Savelieff, M. G., Callaghan, B. C., & Feldman, E. L. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000533 · Cited by 70
Definition of intervention points in prediabetes
Ferrannini, E. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70175-x · Cited by 70
“Prediabetes”: Are There Problems With This Label? Yes, the Label Creates Further Problems!
Yudkin, J. S. (2016) · Diabetes Care · doi:10.2337/dc15-2113 · Cited by 69
Food structure is critical for optimal health
Wahlqvist, M. L. (2015) · Food & Function · doi:10.1039/c5fo01285f · Cited by 71
Prediabetic Neuropathy: Does It Exist?
Παπάνας, Ν., & Ziegler, D. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0278-3 · Cited by 70
Regression from prediabetes to normal glucose regulation: State of the science
Sallar, A. S., & Dagogo-Jack, S. E. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220915644 · Cited by 68
Uremic Sarcopenia: Clinical Evidence and Basic Experimental Approach
Nishi, H., Takemura, K., Higashihara, T., & Inagi, R. (2020) · Nutrients · doi:10.3390/nu12061814 · Cited by 64
Ranjit Unnikrishnan, I., Shaw, J. E., Chan, J. C. N., Wild, S. H., Peters, A. L., Orrange, S., Roden, M., & Mohan, V. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00635-0 · Cited by 69
Physical activity, ethnicity and cardio-metabolic health: Does one size fit all?
Gill, J. M. R., Celis-Morales, C. A., & Ghouri, N. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.11.039 · Cited by 59
Zheng, L., Wang, Y., Hao, S., Shin, A. Y., Jin, B., Ngo, A. D., Jackson-Browne, M. S., Feller, D. J., Fu, T., Zhang, K., et al. (2016) · JMIR Medical Informatics · doi:10.2196/medinform.6328 · Cited by 54
Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial
Holman, R. R., Bethel, M. A., Chan, J. C. N., Chiasson, J., Doran, Z., Ge, J., Gerstein, H. C., Huo, Y., McMurray, J. J. V., Rydén, L., et al. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.03.021 · Cited by 56
Self-citationGong, Q., Kang, J.-F., Ying, Y., Li, H., Zhang, X., Wu, Y., & Xu, G. (2015) · Internal Medicine · doi:10.2169/internalmedicine.54.2745 · Cited by 55
Self-citationSex-specific differences in diabetes prevention: a systematic review and meta-analysis
Glechner, A., Harreiter, J., Gartlehner, G., Rohleder, S., Kautzky, A., Tuomilehto, J. O., Noord, M. V., Kaminski-Hartenthaler, A., & Kautzky‐Willer, A. (2014) · Diabetologia · doi:10.1007/s00125-014-3439-x · Cited by 56
Long, G. H., Cooper, A., Wareham, N. J., Griffin, S. J., & Simmons, R. K. (2014) · Diabetes Care · doi:10.2337/dc13-1731 · Cited by 51
Yun, J., Lim, T., Cha, S., Ahn, Y., Song, K., Choi, J. A., Kwon, J., Jee, D., Cho, Y. K., Park, Y., et al. (2016) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2016.40.6.482 · Cited by 56
Cefalu, W. T. (2016) · Diabetes Care · doi:10.2337/dc16-1143 · Cited by 50
Life style intervention improves retinopathy status-the Finnish Diabetes Prevention Study
Aro, A., Kauppinen, A., Kivinen, N., Selander, T., Kinnunen, K., Tuomilehto, J., Keinänen-Kiukaanniemi, S., Lindström, J., Uusitupa, M., & Kaarniranta, K. (2019) · Nutrients · doi:10.3390/nu11071691 · Cited by 46
Zhang, H., Ni, J., Yu, C., Wu, Y., Li, J., Liu, J., Tu, J., Ning, X., He, Q., & Wang, J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00658 · Cited by 51
Self-citationWaldeyer, R., Brinks, R., Rathmann, W., Giani, G., & Icks, A. (2013) · Diabetic Medicine · doi:10.1111/dme.12177 · Cited by 46
Diabetes: An Update on the Pandemic and Potential Solutions
Ali, M. K., Siegel, K. R., Chandrasekar, E. K., Tandon, N., Montoya, P. A., Mbanya, J. C., Chan, J. C. N., Zhang, P., & Narayan, K. M. V. (2017) · World Bank, Washington, DC eBooks · doi:10.1596/978-1-4648-0518-9_ch12 · Cited by 45
Self-citationAn, X., Zhang, Y., Sun, W., Kang, X., Ji, H., Sun, Y., Jiang, L., Zhao, X., Gao, Q., Lian, F., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1294819 · Cited by 54
Arreola, E. V., Gong, Q., Hanson, R. L., Wang, J., Sandforth, L., He, S., Sandforth, A., Qian, X., Giacca, M., Bornstein, S. R., et al. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00295-5 · Cited by 48
Self-citationmiR-10b and miR-223-3p in serum microvesicles signal progression from prediabetes to type 2 diabetes
Párrizas, M., Mundet, X., Castaño, C., Canivell, S., Cos, X., Brugnara, L., Giráldez‐García, C., Regidor, E., Mata‐Cases, M., Franch‐Nadal, J., et al. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01129-z · Cited by 43
Ziegler, D., Herder, C., & Παπάνας, Ν. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3693 · Cited by 45
Liu, X., Li, C., Gong, H., Cui, Z., Fan, L., Yu, W., Zhang, C., & Ma, J. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-729 · Cited by 45
Gregg, E. W., Boyle, J. P., Thompson, T. J., Barker, L. E., Albright, A. L., & Williamson, D. F. (2013) · Population Health Metrics · doi:10.1186/1478-7954-11-18 · Cited by 45
Self-citationKandula, N. R., Moran, M. R., Tang, J. W., & O’Brien, M. J. (2017) · Clinical Diabetes · doi:10.2337/cd17-0049 · Cited by 47
Gong, Q., Zhang, P., Wang, J., An, Y., Gregg, E. W., Li, H., Zhang, B., Shuai, Y., Yang, W., Chen, Y., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0429 · Cited by 39
Self-citationKang, S., Kang, S. M., Choi, J. H., Ko, S., Koo, B. K., Kwon, H.-S., Kim, M. K., Kim, S. Y., Kim, S., Kim, Y., et al. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0469 · Cited by 44
Narayan, K. M. V., Echouffo-Tcheugui, J. B., Mohan, V., & Ali, M. K. (2012) · Health Affairs · doi:10.1377/hlthaff.2011.1040 · Cited by 35
Maternal Race/Ethnicity and Postpartum Diabetes Screening: A Systematic Review and Meta-Analysis
Herrick, C., Puri, R., Rahaman, R., Hardi, A., Stewart, K. A., & Colditz, G. A. (2020) · Journal of Women s Health · doi:10.1089/jwh.2019.8081 · Cited by 33
Nutritional Strategies in Prediabetes: A Scoping Review of Recent Evidence
Yau, J. W., Thor, S. M., & Ramadas, A. (2020) · Nutrients · doi:10.3390/nu12102990 · Cited by 32
Davies, M. J., Lim, S. K., Slater, T., Goldney, J., Philis‐Tsimikas, A., Franco, D. R., Lamptey, R., Yates, T. E., Tankova, T. I., & Lingvay, I. (2026) · Nature Reviews Disease Primers · doi:10.1038/s41572-026-00687-w · Cited by 45
Diabetic nephropathy - Epidemiology in Asia and the current state of treatment
Ritz, E., & Zeng, X. (2011) · Indian Journal of Nephrology · doi:10.4103/0971-4065.82122 · Cited by 30
Wei, S., Brejnrod, A., Trivedi, U., Mortensen, M. S., Johansen, M. Y., Karstoft, K., Vaag, A. A., Ried‐Larsen, M., & Sørensen, S. J. (2021) · Gut Microbes · doi:10.1080/19490976.2021.2005407 · Cited by 27
Reducing the Risk of Developing Diabetes
Ransom, T. P. P., Goldenberg, R., Mikalachki, A., Prebtani, A. P. H., & Punthakee, Z. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.013 · Cited by 29
Clinical Research of Traditional Chinese Medical Intervention on Impaired Glucose Tolerance
Gao, Y., Zhou, H., Zhao, H., Feng, X., Feng, J., Li, Y., Zhang, H., Lü, H., Qian, Q., Yu, X., et al. (2013) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x1350002x · Cited by 27
Wu, Z., Jin, T., & Weng, J. (2018) · Science China Life Sciences · doi:10.1007/s11427-018-9377-y · Cited by 27
Wang, Q., Zeng, N., Tang, H., Yang, X., Yao, Q., Zhang, L., Zhang, H., Zhang, Y., Nie, X., Liao, X., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.993423 · Cited by 27
Neuromuscular Complications of Diabetes Mellitus
Bril, V. (2014) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000450964.30710.a0 · Cited by 25
Bönhof, G. J., Herder, C., & Ziegler, D. (2021) · Current Diabetes Reviews · doi:10.2174/1573399817666210412123740 · Cited by 25
Chen, X., Wu, Z., Chen, Y., Wang, X., Zhu, J., Wang, N., Jiang, Q., & Fu, C. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0680-4 · Cited by 26
Li, X., Wang, J., Shen, X., An, Y., Gong, Q., Li, H., Zhang, B., Shuai, Y., Chen, Y., Hu, Y., et al. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12887 · Cited by 25
Self-citation
Metadata
- Authors
- Gong, Q., Gregg, E. W., Wang, J., An, Y., Zhang, P., Yang, W., Li, H., Li, H., Jiang, Y., Shuai, Y., Zhang, B., Zhang, J., Gerzoff, R. B., Roglic, G., Hu, Y., Li, G., & Bennett, P. H.
- Affiliations
- China-Japan Friendship Hospital (CN)
- Centers for Disease Control and Prevention (US)
- Daqing Oilfield General Hospital (CN)
- National Institutes of Health (US)
- Corresponding author
- Li, G.
- Venue
- Diabetologia
- Published
- 2010-11-03
- Volume
- 54
- Issue
- 2
- Pages
- 300-307
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2067941747
- Cited by
- 251
- References
- 32
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 14 · 2023: 12 · 2022: 15 · 2021: 11 · 2020: 12 · 2019: 16 · 2018: 20 · 2017: 17 · 2016: 18 · 2015: 29 · 2014: 25 · 2013: 22 · 2012: 14
- FWCI
- 10.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- American Diabetes Association
- Centers for Disease Control and Prevention (U58/CCU424123‐01‐02)
- U.S. Public Health Service (U58/CCU424123-01-02)
- China-Japan Friendship Hospital
- National Institute of Diabetes and Digestive and Kidney Diseases
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Keywords
- impaired glucose tolerance, lifestyle intervention, diabetes prevention, diabetic retinopathy, diabetic nephropathy, diabetic neuropathy, microvascular complications, diet and exercise, long-term follow-up
- MeSH terms
- Adult, Diabetes Mellitus, Diabetic Nephropathies, Diabetic Neuropathies, Female, Humans, Life Style, Male, Middle Aged, Glucose Intolerance, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
